208 related articles for article (PubMed ID: 24108539)
1. Effect of F8 B domain gene variants on synthesis, secretion, activity and stability of factor VIII protein.
Pahl S; Pavlova A; Driesen J; Oldenburg J
Thromb Haemost; 2014 Jan; 111(1):58-66. PubMed ID: 24108539
[TBL] [Abstract][Full Text] [Related]
2. Characterization of five associations of F8 missense mutations containing FVIII B domain mutations.
Jourdy Y; Nougier C; Roualdes O; Fretigny M; Durand B; Negrier C; Vinciguerra C
Haemophilia; 2016 Jul; 22(4):583-9. PubMed ID: 26915717
[TBL] [Abstract][Full Text] [Related]
3. Variation in baseline factor VIII concentration in a retrospective cohort of mild/moderate hemophilia A patients carrying identical F8 mutations.
Loomans JI; van Velzen AS; Eckhardt CL; Peters M; Mäkipernaa A; Holmstrom M; Brons PP; Dors N; Haya S; Voorberg J; van der Bom JG; Fijnvandraat K
J Thromb Haemost; 2017 Feb; 15(2):246-254. PubMed ID: 27943580
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of an in vitro cellular expression model for haemophilia A carrier diagnosis: illustration with five novel mutations in the F8 gene in women with isolated factor VIII:C deficiency.
Roualdes O; Nougier C; Fretigny M; Talagrand E; Durand B; Negrier C; Vinciguerra C
Haemophilia; 2015 May; 21(3):e202-e209. PubMed ID: 25708597
[TBL] [Abstract][Full Text] [Related]
5. Haemophilia A mutations in patients with non-severe phenotype associated with a discrepancy between one-stage and chromogenic factor VIII activity assays.
Pavlova A; Delev D; Pezeshkpoor B; Müller J; Oldenburg J
Thromb Haemost; 2014 May; 111(5):851-61. PubMed ID: 24452774
[TBL] [Abstract][Full Text] [Related]
6. Mild hemophilia A patient with novel Pro1809Leu mutation develops an anti-C2 antibody inhibiting allogeneic but not autologous factor VIII activity.
Yada K; Nogami K; Takeyama M; Ogiwara K; Wakabayashi H; Shima M
J Thromb Haemost; 2015 Oct; 13(10):1843-53. PubMed ID: 26278069
[TBL] [Abstract][Full Text] [Related]
7. Clustered
Donadon I; McVey JH; Garagiola I; Branchini A; Mortarino M; Peyvandi F; Bernardi F; Pinotti M
Haematologica; 2018 Feb; 103(2):344-350. PubMed ID: 29170251
[TBL] [Abstract][Full Text] [Related]
8. In silico analyses of missense mutations in coagulation factor VIII: identification of severity determinants of haemophilia A.
Sengupta M; Sarkar D; Ganguly K; Sengupta D; Bhaskar S; Ray K
Haemophilia; 2015 Sep; 21(5):662-9. PubMed ID: 25854144
[TBL] [Abstract][Full Text] [Related]
9. Genetic analysis of non-severe hemophilia A phenotype with A discrepancy between one-stage and chromogenic factor VIII activity assays.
Valikhani A; Mirakhorly M; Namvar A; Rastegarlari G; Toogeh G; Shirayeh FV; Ahmadinejad M
Transfus Apher Sci; 2021 Oct; 60(5):103194. PubMed ID: 34275734
[TBL] [Abstract][Full Text] [Related]
10. In silico calculated affinity of FVIII-derived peptides for HLA class II alleles predicts inhibitor development in haemophilia A patients with missense mutations in the F8 gene.
Pashov AD; Calvez T; Gilardin L; Maillère B; Repessé Y; Oldenburg J; Pavlova A; Kaveri SV; Lacroix-Desmazes S
Haemophilia; 2014 Mar; 20(2):176-84. PubMed ID: 24118514
[TBL] [Abstract][Full Text] [Related]
11. Most factor VIII B domain missense mutations are unlikely to be causative mutations for severe hemophilia A: implications for genotyping.
Ogata K; Selvaraj SR; Miao HZ; Pipe SW
J Thromb Haemost; 2011 Jun; 9(6):1183-90. PubMed ID: 21645226
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms of missense mutations that generate ectopic N-glycosylation sites in coagulation factor VIII.
Wei W; Misra S; Cannon MV; Yang R; Zhu X; Gilmore R; Zhu M; Zhang B
Biochem J; 2018 Mar; 475(5):873-886. PubMed ID: 29444815
[TBL] [Abstract][Full Text] [Related]
13. Identification of deep intronic variants in 15 haemophilia A patients by next generation sequencing of the whole factor VIII gene.
Bach JE; Wolf B; Oldenburg J; Müller CR; Rost S
Thromb Haemost; 2015 Oct; 114(4):757-67. PubMed ID: 25948085
[TBL] [Abstract][Full Text] [Related]
14. Missense mutations near the N-glycosylation site of the A2 domain lead to various intracellular trafficking defects in coagulation factor VIII.
Wei W; Zheng C; Zhu M; Zhu X; Yang R; Misra S; Zhang B
Sci Rep; 2017 Mar; 7():45033. PubMed ID: 28327546
[TBL] [Abstract][Full Text] [Related]
15. In silico and in vitro evaluation of the impact of mutations in non-severe haemophilia A patients on assay discrepancies.
Pezeshkpoor B; Gazorpak M; Berkemeier AC; Singer H; Pavlova A; Biswas A; Oldenburg J
Ann Hematol; 2019 Aug; 98(8):1855-1865. PubMed ID: 30997536
[TBL] [Abstract][Full Text] [Related]
16. Stable recombinant expression and characterization of the two haemophilic factor VIII variants C329S (CRM(-)) and G1948D (CRM(r)).
David D; Saenko EL; Santos IM; Johnson DJ; Tuddenham EG; McVey JH; Kemball-Cook G
Br J Haematol; 2001 Jun; 113(3):604-15. PubMed ID: 11380445
[TBL] [Abstract][Full Text] [Related]
17. Characterization of F8 defects in haemophilia A in Pakistan: investigation of correlation between mutation type and the in vitro thrombin generation assay.
Khanum F; Collins PW; Harris RL; Bowen DJ
Haemophilia; 2014 Mar; 20(2):287-93. PubMed ID: 24118398
[TBL] [Abstract][Full Text] [Related]
18. Clinical manifestation of hemophilia A in the absence of mutations in the F8 gene that encodes FVIII: role of microRNAs.
Jankowska KI; McGill J; Pezeshkpoor B; Oldenburg J; Atreya CD; Sauna ZE
Transfusion; 2020 Feb; 60(2):401-413. PubMed ID: 31785023
[TBL] [Abstract][Full Text] [Related]
19. [Molecular analysis of a patient with hemophilia A caused by FVIII His99Arg mutation].
Qin HH; Wang XF; Ding QL; Lu YL; Dai J; Xi XD; Wang HL
Zhonghua Xue Ye Xue Za Zhi; 2011 Sep; 32(9):587-91. PubMed ID: 22338150
[TBL] [Abstract][Full Text] [Related]
20. Expression studies of mutant factor VIII alleles with premature termination codons with regard to inhibitor formation.
Zimmermann MA; Oldenburg J; Müller CR; Rost S
Haemophilia; 2014 May; 20(3):e215-21. PubMed ID: 24602271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
